MYRIAD GENETICS INC's ticker is MYGN and the CUSIP is 62855J104. A total of 264 filers reported holding MYRIAD GENETICS INC in Q1 2019. The put-call ratio across all filers is 2.77 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2019 | $5,109,000 | +18.9% | 153,896 | +4.1% | 0.01% | 0.0% |
Q4 2018 | $4,298,000 | -63.2% | 147,864 | -41.8% | 0.01% | -14.3% |
Q3 2018 | $11,680,000 | +151.1% | 253,896 | +104.0% | 0.01% | +16.7% |
Q2 2018 | $4,651,000 | +33.7% | 124,458 | +5.7% | 0.01% | +20.0% |
Q1 2018 | $3,478,000 | -14.0% | 117,695 | 0.0% | 0.01% | 0.0% |
Q4 2017 | $4,042,000 | -3.5% | 117,695 | +1.7% | 0.01% | -16.7% |
Q3 2017 | $4,188,000 | +40.4% | 115,747 | +0.3% | 0.01% | +50.0% |
Q2 2017 | $2,982,000 | +32.8% | 115,407 | -1.3% | 0.00% | +33.3% |
Q1 2017 | $2,245,000 | +16.4% | 116,924 | +1.1% | 0.00% | 0.0% |
Q4 2016 | $1,928,000 | -15.3% | 115,637 | +4.6% | 0.00% | -25.0% |
Q3 2016 | $2,276,000 | -32.7% | 110,586 | 0.0% | 0.00% | -33.3% |
Q2 2016 | $3,384,000 | -21.3% | 110,586 | -3.7% | 0.01% | -25.0% |
Q1 2016 | $4,300,000 | -1.7% | 114,875 | +13.3% | 0.01% | 0.0% |
Q4 2015 | $4,375,000 | +13.6% | 101,366 | -1.3% | 0.01% | 0.0% |
Q3 2015 | $3,850,000 | +10.3% | 102,716 | 0.0% | 0.01% | +33.3% |
Q2 2015 | $3,491,000 | +87.4% | 102,716 | +95.2% | 0.01% | +100.0% |
Q1 2015 | $1,863,000 | -1.3% | 52,615 | -5.0% | 0.00% | -25.0% |
Q4 2014 | $1,887,000 | -0.4% | 55,410 | +12.8% | 0.00% | 0.0% |
Q3 2014 | $1,895,000 | +0.8% | 49,141 | +1.7% | 0.00% | 0.0% |
Q2 2014 | $1,880,000 | +0.7% | 48,311 | -11.5% | 0.00% | 0.0% |
Q1 2014 | $1,867,000 | +53.7% | 54,614 | -5.7% | 0.00% | +33.3% |
Q4 2013 | $1,215,000 | +8.7% | 57,892 | +21.7% | 0.00% | 0.0% |
Q3 2013 | $1,118,000 | -12.6% | 47,557 | -0.1% | 0.00% | 0.0% |
Q2 2013 | $1,279,000 | – | 47,593 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Camber Capital Management LP | 5,000,000 | $90,850,000 | 3.94% |
Altium Capital Management LP | 221,000 | $4,016,000 | 1.61% |
DISCIPLINED GROWTH INVESTORS INC /MN | 1,900,787 | $34,537,000 | 0.93% |
Zebra Capital Management LLC | 15,352 | $279,000 | 0.82% |
PFM Health Sciences, LP | 1,177,250 | $21,391,000 | 0.82% |
EARNEST PARTNERS LLC | 6,462,138 | $117,417,000 | 0.78% |
Glenview Capital Management | 1,696,791 | $30,831,000 | 0.77% |
AIMZ Investment Advisors, LLC | 42,085 | $765,000 | 0.37% |
Phocas Financial Corp. | 127,949 | $2,325,000 | 0.35% |
Redhawk Wealth Advisors, Inc. | 34,680 | $630,000 | 0.29% |